Loading...

Neurocrine Biosciences, Inc.

NBIX•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$133.56
$0.81(0.61%)

Neurocrine Biosciences, Inc. (NBIX) Stock Chart & Performance Analysis

Explore Neurocrine Biosciences, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-4.79%
5-Day Change
-8.73%
1-Month Change
-18.17%
3-Month Change
-35.61%
6-Month Change
-19.30%
Year-to-Date (YTD) Change
-34.19%
1-Year Change
-34.30%
3-Year Change
-7.87%
5-Year Change
-5.45%
All-Time (Max) Change
625.76%

Analyzing Neurocrine Biosciences, Inc. (NBIX) Trends Across Multiple Time Frames

Neurocrine Biosciences, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Neurocrine Biosciences, Inc. stock shows -4.79% 1-day change, indicating low volatility, while its 5-day change of -8.73% suggests a broader trend. Over a 1-month period, a -18.17% drop could signal a pullback, whereas a 3-month decline of -35.61% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -19.30% and a YTD drop of -34.19% might concern investors, but a 1-year loss of -34.30% and a 3-year drop of -7.87% could indicate resilience. The 5-year surge of -5.45% highlights weak historical growth, while the all-time return of 625.76% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;